Goodman Gilman'S Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 21-12-2024
- Paid Up Capital ₹ 0.37 M
as on 21-12-2024
- Company Age 13 Year, 13 Days
- Last Filing with ROC 31 Mar 2024
- Revenue 14.39%
(FY 2020)
- Profit 6.16%
(FY 2020)
- Ebitda -90.38%
(FY 2020)
- Net Worth 25.20%
(FY 2020)
- Total Assets 13.68%
(FY 2020)
About Goodman Gilman'S Life Sciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.37 M, as per Ministry of Corporate Affairs (MCA) records.
Chaman Rana and Neeraj Rana serve as directors at the Company.
- CIN/LLPIN
U24232DL2011PTC228654
- Company No.
228654
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Dec 2011
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Goodman Gilman'S Life Sciences?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Chaman Rana  | Director | 13-Dec-2011 | Current |
| Neeraj Rana | Director | 13-Dec-2011 | Current |
Financial Performance of Goodman Gilman'S Life Sciences.
Goodman Gilman'S Life Sciences Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 14.39% increase. The company also saw a slight improvement in profitability, with a 6.16% increase in profit. The company's net worth Soared by an impressive increase of 25.2%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Goodman Gilman'S Life Sciences?
In 2018, Goodman Gilman'S Life Sciences had a promoter holding of 71.00% and a public holding of 29.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Goodman Gilman'S Life Sciences?
Goodman Gilman'S Life Sciences has a workforce of 15 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Goodman Gilman'S Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Goodman Gilman'S Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
